Procter & Gamble (PG) FY2025 Earnings Quality Report

Grade: F — Major Red Flags

Framework: Schilit *Financial Shenanigans* + Beneish M-Score + forensic accounting principles

Data: SEC EDGAR 10-K (Filed 2025-08-04, FY ended June 30, 2025) + Yahoo Finance

Auditor: Deloitte & Touche LLP — Unqualified opinion

One-line verdict: Procter & Gamble is a $84.3B revenue behemoth with global market leadership across beauty, grooming, health care, fabric & home care, and baby care — brands like Tide, Pampers, Gillette, Crest, and Charmin. Operating margin expanded 220 basis points to 24.3%, and net earnings grew 7% to $16.0B, partly boosted by the lapping of FY2024's $1.3B Gillette intangible impairment. Cash flow is strong but declining: CFFO fell 10% to $17.8B, with adjusted free cash flow productivity at 87% — below management's 90% target. Three quantitative flags trigger the F: AR outpacing revenue for two consecutive years, cash of $9.6B covering only 27% of $35.5B in debt, and goodwill plus intangibles of $63.6B at 122% of equity. P&G just announced a $1.5-2.0B restructuring plan to eliminate up to 7,000 non-manufacturing jobs, and the Glad joint venture with Clorox is being terminated. This is the world's highest-quality F grade — an operationally excellent business with a balance sheet weighed down by acquisition-era intangibles and systematic share buyback-driven equity erosion.

The Business: Five Sector Business Units with Global Dominance

P&G's five SBUs each hold commanding market positions:

Per the filing: "Net sales increased low single digits in Health Care and was unchanged in Grooming, Fabric & Home Care and Baby, Feminine & Family Care. Net sales decreased low single digits in Beauty."

Organic sales increased 2%, driven by pricing of 1% and mix improvements, with flat volume excluding acquisitions/divestitures.

Profitability: Margin Expansion on Flat Revenue

Gross margin contracted 20 basis points to 51.2% from "110 basis points of decline from unfavorable product mix, 50 basis points of product and packaging investments, 30 basis points of higher commodity costs," partially offset by "180 basis points of manufacturing productivity savings." SG&A as a percentage of net sales decreased 80 basis points to 26.9% due to marketing productivity and lower marketing spending.

The prior year included the $1.3B Gillette intangible impairment ("due to a higher discount rate, weakening of several currencies relative to the U.S. dollar and the impact of the non-core restructuring program").

Cash Flow: Strong but Declining

Per the filing: "Operating cash flow was $17.8 billion in 2025, a 10% decrease versus the prior year." Working capital consumed $2.5B, driven by inventory increases ($324M for safety stock and higher commodity costs), accounts payable decreases ($542M from marketing activities), and "other impacts" including "$806 [million] postretirement benefit impacts" and "$562 [million] payment of the transitional tax related to the 2017 U.S. Tax Act."

Adjusted free cash flow productivity of 87% missed the company's own 90% target. CapEx increased to $3.8B, driven by capacity investments across SBUs.

The 18-Point Screening

Revenue Quality

A2 — AR growth outpacing revenue. In a company with virtually flat revenue (+0.3%), growing receivables suggest timing shifts or changes in customer payment patterns. This is a mild flag for P&G given the company's scale and diverse customer base, but two consecutive years of divergence merits noting.

Expense Quality

Cash Flow Quality

Balance Sheet

D1 — Acquisition-era intangibles. The $63.6B in goodwill and intangibles derives primarily from the 2005 Gillette acquisition and the 2014 Duracell divestiture era. Total equity of $52.2B supports this intangible base, but the ratio of 122% means any significant impairment beyond Gillette would create pressure. P&G's low leverage (1.5x Debt/EBITDA) and strong Z-Score (4.70) provide substantial offset.

C4 — Manageable debt in context. While cash of $9.6B covers only 27% of $35.5B in total debt, P&G maintains an $8.0B revolving credit facility (split between a $3.2B five-year and $4.8B 364-day facility), both undrawn. The company's debt maturities are well-laddered: $5.4B in FY2026, $4.6B in FY2027, $2.1B in FY2028.

Acquisition Risk

Manipulation Score

Key Risks from the 10-K

1. $1.5-2.0B Restructuring Plan — 7,000 Job Cuts

"In June 2025, the Company announced a portfolio and productivity plan to streamline its portfolio and organization to improve its cost structure and competitiveness." Half the costs will be incurred by FY2026, with the remainder in FY2027. The plan targets "a reduction of up to 7,000 non-manufacturing overhead personnel."

2. Glad Joint Venture Termination

"The Company and The Clorox Company have jointly decided not to renew the Glad joint venture agreement. Under the terms of the agreement, Clorox will purchase the Company's minority interest in the venture at fair market value." This ends a long-standing partnership.

3. Argentina Liquidation — $1.2B After-Tax Charge

"During the period ended September 30, 2024, the Company completed this limited market portfolio restructuring with the substantial liquidation of its operations in Argentina and recorded incremental restructuring charges of $801 million after tax, comprised primarily of non-cash charges for accumulated foreign currency translation losses." Total charges since inception: $1.2B after tax.

4. Greater China Headwinds

Beauty segment in Greater China saw a "high single-digit decline" in organic sales due to "market contraction and the impact of divestitures." SK-II, P&G's super-premium skincare brand, faces secular challenges as Chinese consumers shift preferences.

5. Private Label and Hard Discounter Competition

"Evolving sales channels and business models may affect customer and consumer preferences as well as market dynamics, which, for example, may be seen in the growing consumer preference for shopping online, ease of competitive entry into certain categories and growth in hard discounter channels."

Summary

Grade: F. Three quantitative flags on the world's most operationally excellent consumer staples company. The F reflects balance sheet structure, not operating quality.

P&G generates $16.0B in net income, $17.8B in operating cash flow, and holds 30%+ market share in virtually every category it competes in. Gross margin of 51.2% and operating margin of 24.3% are best-in-class. The M-Score of -2.53, accruals of -1.5%, and Deloitte's clean audit opinion confirm high earnings quality. The Z-Score of 4.70 is firmly in the safe zone.

The F grade is driven by structural factors: $63.6B in acquisition-era intangibles (mainly Gillette), $35.5B in debt from decades of capital return, and a mild AR divergence. With Debt/EBITDA of just 1.5x and interest coverage exceeding 20x, P&G's debt service capacity is unquestioned. The newly announced $1.5-2.0B restructuring plan and 7,000 job cuts signal proactive cost management, not distress. This is the strongest business receiving an F grade in our coverage — the grade reflects balance sheet screening thresholds, not business quality.

**Disclaimer**: This report is based on The Procter & Gamble Company's FY2025 10-K filed with SEC EDGAR on August 4, 2025. This is NOT investment advice.

Data: SEC EDGAR 10-K + Yahoo Finance

Auditor: Deloitte & Touche LLP (Unqualified opinion)

Fiscal year ended: June 30, 2025